// App-Quantinova.ai

OP0296 (2021) : THE 2021 DORIS DEFINITION OF REMISSION IN SLE – FINAL RECOMMENDATIONS FROM AN INTERNATIONAL TASK FORCE

Researchers

Presenter

  • R. van Vollenhoven

Principal Investigators

  • A. Doria

  • D. Isenberg

  • E. F. Morand

  • M. A. Petri

  • B. Pons-Estel

  • A. Rahman

  • M. Ugarte-Gil

  • A. Voskuyl

  • L. Arnaud

  • I. N. Bruce

  • R. Cervera

  • N. Costedoat-Chalumeau

  • C. Gordon

  • F. Houssiau

  • M. Mosca

  • M. Schneider

  • M. Ward

  • C. Aranow

Medical Centers

  • Amsterdam Rheumatology and Immunology Center, Amsterdam, Netherlands

  • University of Crete, Rheumatology, Heraklion, Greece

  • University of Padova, neurosciences, Padova, Italy

  • University College London, Gastroenterology, London, United Kingdom

  • Monash University, School of Clinical Sciences, Melbourne, Australia

  • The Johns Hopkins University, Baltimore, United States of America

  • Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Grupo Oroño,Rosario, Rosario, Argentina

  • Universidad Cientifica Del Sur, Lima, Peru

  • University Hospital of Strasbourg, Strasbourg, France

  • School of Biological Sciences The University of Manchester, Division of Musculoskeletal and Dermatological Sciences, Manchester, United Kingdom

  • Hospital Clinic de Barcelona, Autoimmune Diseases, Barcelona, Spain

  • Cochin Hospital, Internal Medicine, Paris, France

  • University Hospital Birmingham Rheumatology Dept, Birmingham, United Kingdom

  • University of Pisa, Italy, Pisa, Italy

  • Heinrich-Heine University, Rheumatology, Dusseldorf, Germany

  • NIAMS/NIH, Intramural Research Program, Bethesda, United States of America

  • The Feinstein Institute for Medical Research, Manhasset, United States

Locations

  • Netherlands

  • Greece

  • Italy

  • United Kingdom

  • Australia

  • United States

  • Argentina

  • Peru

  • France

  • Spain

  • Belgium

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • BMS Infotech

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved